Wake Forest University Baptist Health is a clinical research site located in Winston-Salem, North Carolina, United States 27103.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Wake Forest University Baptist Health has participated in 7 clinical trials with 4 currently active.
Therapeutic areas: Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP), Gastric Adenocarcinoma.
Sponsors: Tanabe Pharma America, Inc., Astellas Pharma Global Development, Inc., Wake Forest University Health Sciences.
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Wake Forest University Baptist Health has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Wake Forest University Baptist Health has 7 clinical trials on record, with 4 currently active. Their work covers Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP), Gastric Adenocarcinoma.
Yes — Wake Forest University Baptist Health holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.